Pfizer is preparing to raise its offer for obesity drugmaker Metsera after a U.S. judge refused to block rival Novo Nordisk’s $10 billion bid, according to a source. The pharmaceutical giant is scrambling to keep its takeover plans alive as its current merger agreement with Metsera is set to expire at midnight ET without an […]